Call for Abstracts

Dear abstract authors,

We are very pleased you are interested in submitting your research abstract to the 2023 American Society of Hematology meeting -- the premier global meeting in hematology -- being held in San Diego, California, December 9-12, 2023. Before you begin the process, I would like to highlight several changes in our abstract format and in abstract categories and give you more information regarding requirements for presentation of abstracts at the annual meeting. Your close attention is necessary to give your abstract the best chance for inclusion in the annual meeting as an oral session presentation or poster.

• Abstracts will be limited to 3,800 characters to be accommodated on our digital platform.
• Abstracts may include no more than two panels of additional content. A "panel" would be defined as a table or a single graphical representation of data (ie equivalent to a figure panel in a paper, not to a multi-panel figure).

Please carefully review all descriptions before selecting a category for your abstract. Categories are updated every year to respond to submission trends and to encompass new topics. This year, updates have been made to multiple category descriptions with significant changes as follows:

• *NEW* Category 654: MGUS, Amyloidosis and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological
• Clinical and epidemiological studies in MGUS, amyloidosis, or other non-myeloma plasma cell dyscrasias; and prospective clinical trials in MGUS, amyloidosis, or other non-myeloma plasma cell dyscrasias, formerly submitted to categories 652 and 653 respectively should be submitted to the new category 654.

ASH reserves the right to move your abstract to a more appropriate category if misplacement is noted by the Secretary during abstract processing; however, correct categorization at the time of submission is the author's responsibility and will ensure the highest quality review process.

The 65th Annual Meeting of the American Society of Hematology (ASH) will be held Saturday, December 9, through Tuesday, December 12, 2023, in San Diego, California. The meeting will be in person, with a virtual attendance option, however, presenting authors are expected to be on-site San Diego. If the first author is unable to attend in person, another abstract author able to attend in person may be substituted as the presenter. We realize decisions about attendance may not be feasible before the abstract submission deadline and we will accommodate changes as neccessary. ASH is committed to providing a safe and healthy environment for all attendees and continually monitors the state of the COVID-19 pandemic. We encourage you to monitor this page to stay abreast of any updates to the health and safety information for the 65th ASH Annual Meeting and Exposition in San Diego, California.

• Poster presenters will be required to submit pre-recorded presentations and PDFs of their posters by November 14th.
• ASH reminds authors that the last date to withdraw abstracts from the annual meeting is September 15, 2023.

The link to our submission process is provided here for ease of access. For questions about the abstract submission process, contact ashabstracts@hematology.org.

We look forward seeing you in San Diego and hearing about your current research in hematology!

Sincerely,

Cynthia Dunbar, MD
ASH Secretary

Please Note: - Pre-recorded presentations for poster presentations are required by November 14th.
 
Poster presentations will consist of 3-5 minute recordings accompanying a slide deck on the virtual platform. Printed posters will be hung in the poster hall for those attending in-person, and the poster images will also be available on the virtual platform.
 
Failure to submit a presentation by November 14th will result in removal of presenting privileges, to be noted by "Presentation Not Available" in meeting materials.

Eligibility

To submit an abstract, the following criteria must be met

• At least one of the authors must be an ASH member, who has paid the current membership dues.

  If none of the abstract authors is an ASH member, the abstract must be sponsored by a current ASH member or it will not be reviewed. ASH members are urged to use their judgment in restricting sponsorship to a reasonable number of abstracts, keeping in mind that they are endorsing the authenticity and quality of each abstract that they sponsor.

• Research and/or studies must fit into one of the ASH 2023 Abstract Review Categories.
• Updated analyses will be considered only if the abstract is a significant extension of previously published work. The author must provide an explanation to show how the abstract contains significant new information.

  *Note: Abstracts submitted to other ASH meetings (e.g., the 2019 Meetings on Lymphoma and Hematologic Malignancies) are exempted from the above meeting-size restriction and are eligible to be re-submitted to the 2023 ASH Annual Meeting.

Any of the following criteria will make an abstract ineligible for presentation at the ASH annual meeting

• Data from peer-reviewed content publicly available via major search engines (such as PubMed, Google Scholar, etc.,)
• Data are accepted for journal publication before the abstract submission closing date.
• Data have been or are to be presented at a meeting of 1,000 or more participants before January 1, 2023.*
• Data are to be presented at an ASH Friday Satellite Symposium, scheduled for December 8, 2023.

Updated analyses of work previously presented at ASH or other meetings of more than 1,000 participants will be considered only if the abstract is a significant extension of previously presented work. The author must provide an explanation documenting the significant new information

Responsibilities of the Presenting Author

• The first author listed for each abstract serves as the presenting author and as the primary contact for all correspondence regarding the abstract, unless otherwise specified under the "Contact Information" section of the online abstract submission system.
• The presenting author must be one of the co-authors listed on the submitted abstract.
• In contrast to past years, oral abstract and poster presentations will no longer be contained in the ACCME-accredited portion of the annual meeting. Therefore, presenting authors are no longer subject to ACCME restrictions, and can be employees of publicly-traded or privately-held healthcare companies or owners of privately-held entities. All relevant conflicts of interest must be disclosed, and data presented fairly and transparently.
   
  Presenting authors are expected to be on-site in San Diego. The presenter can be changed on the Author(s) step until the August 1 deadline. More information is available here.
• The presenting author is responsible for the following:
• Ensuring that all authors have read the abstract and agreed to be co-authors. Failure to get approval from all authors will result in rejection of the abstract.
• Notifying all co-authors of any additions, deletions, and changes to the program, as may be communicated by ASH.
• Obtaining all the conflict of interest disclosure and copyright transfer information from co-authors.
• Forwarding all correspondence to all co-authors, including the ASH policies and guidelines, and the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support for Continuing Medical Education (CME).

Technical Requirements

The electronic submission system is compatible with PC Windows and Apple computers and with most browsers, including Google Chrome, Mozilla Firefox, Internet Explorer, Safari, and Netscape.

Before you Begin

Have the following information available:

Submission Process

FAQS

Please consider the following before submitting your abstract to the ASH Annual Meeting:

• Q: What is the submission deadline for the abstracts?

  A: The deadline for all abstracts is August 01, 2023 at 11:59 p.m. PDT. Submissions that are incomplete at this time will be rejected without review.

• Q: Can I still submit an abstract if I presented it at another scientific meeting or submitted it to a journal?

  A: Any of the following criteria will make an abstract ineligible for presentation at the ASH annual meeting:

  • Data from peer-reviewed content publicly available via major search engines (such as PubMed, Google Scholar, etc.),
  • Data are accepted for journal publication before the abstract submission closing date.
  • Data have been or are to be presented at a meeting of 1,000 or more participants before the 2023 ASH annual meeting.
  • Data are to be presented at an ASH Friday Satellite Symposium, scheduled for December 8, 2023.

  Data from the long-term follow-up of previously presented clinical trials may be submitted only if significant new information can be shown. In this case, please use the Updated Analyses section of the abstract form to explain the significance of the new data. The reviewers will have this information available during their evaluation.

  *Note: Abstracts submitted to other ASH meetings (e.g., the 2019 Meetings on Lymphoma and Hematologic Malignancies) are exempted from the above meeting-size restriction and are eligible to be re-submitted to the 2023 ASH Annual Meeting.

• Q: How long can the abstracts be?

  A: The abstracts are limited to a maximum of 3,800 characters. Note that this character count does not include spaces. Figures are not included in the character count.

• Q: May I include tables in my abstract?

  A: Yes, but we now ask that any tables that you wish to include must be uploaded as an image. You will not be allowed to paste a table directly into the text of the abstract, but rather you must include it as an image in the appropriate place and use the Upload method. To convert a table to an image, we recommend taking a screenshot of the table. If using a PC, use the Snipping Tool or the Print Screen button. If using a Mac, press Command-Shift-4.

• Q: If I have images in my abstract, what resolution should my images be?

  A: We require a minimum of 300 dpi for all uploaded images. This will insure proper resolution for display.

• Q: How many abstracts can a single author submit?

  A: There is no set limit as to the number of abstracts a single author can submit.

• Q: How many authors can contribute to a single abstract?

  A: There is no set limit to the number of authors who can contribute to a single abstract.

• Q: Do all authors on an abstract have to submit their Conflict-of-Interest disclosures to ASH? How should they do that?

  A: The submitting author must manually enter disclosure information for all authors into the online abstract submission form. Authors must disclose all relationships they may have, regardless of their relevance to an abstract. If an author's COI disclosure form populates with information already supplied, we strongly urge you to use this existing information for that person. If you are aware of a relationship that should be added to that disclosure, you may do so, and the update will be applied all of that individual's disclosures for the entire meeting. Please do NOT delete any existing disclosure information if you are not the person in question. You may wish to use this sample form to collect disclosure information from your coauthors. (Please note that this form should NOT be sent to ASH; you are responsible for entering the information on the form into the online abstract submission system for every author.)

• Q: What if I am not able to submit my abstract at this time?

  A: ASH allows for the submission of late-breaking abstracts, covering ground-breaking research results that were not available by the regular submission deadline. Please note that only six late-breaking abstracts will be accepted for presentation, regardless of how many are submitted. Late-breaking Abstracts may be submitted between October 17 and October 26, 2023.

• Q: What if I need to withdraw my abstract?

  A: The deadline to withdraw an abstract is September 15, 2023 Abstracts cannot be withdrawn after this deadline, and will appear in all meeting publications and in the abstracts issue of Blood.

• Q: When will I know if my abstract has been accepted?

  A: You will receive an e-mail in early-October notifying you if your abstract has been accepted and whether you are invited to present it at the Annual Meeting.

• Q: When will my accepted abstract be published?

  A: Abstracts that are accepted for presentation will be made available online in early November on the ASH annual meeting Program Web site. They will also be published in a mid-November issue of Blood.